Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2

被引：25

作者：

Abbasi, Asim Z. ^{[1
]}

Kiyani, Dania A. ^{[1
]}

Hamid, Syeda M. ^{[1
]}

Saalim, Muhammad ^{[1
,2
]}

Fahim, Ammad ^{[3
]}

Jalal, Nasir ^{[1
,4
]}

机构：

[1] PsiMega2 Pvt Ltd, Islamabad, Pakistan

[2] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China

[3] Natl Univ Med Sci, Rawalpindi, Punjab, Pakistan

[4] Nanjing Univ Informat Sci & Technol, 219 Ningliu Rd, Nanjing, Jiangsu, Peoples R China

来源：

JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 07期

关键词：

coronavirus; COVID-19; differential gene expression; SARS-CoV-2; TMPRSS2; blockers; inhibitors; viral entry; SERINE-PROTEASE; PROSTATE-CANCER; MERS-COV; RECEPTOR; CORONAVIRUS; EXPRESSION; INFECTION; PNEUMONIA; COVID-19; CLONING;

D O I：

10.1002/jmv.26911

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Epidemiological data shows a discrepancy in COVID-19 susceptibility and outcomes with some regions being more heavily affected than others. However, the factors that determine host susceptibility and pathogenicity remain elusive. An increasing number of publications highlight the role of Transmembrane Serine Protease 2 (TMPRSS2) in the susceptibility of the host cell to SARS-CoV-2. Cleavage of viral spike protein via the host cell's TMPRSS2 enzyme activity mediates viral entry into the host cell. The enzyme synthesis is regulated by the TMPRSS2 gene, which has also been implicated in the entry mechanisms of previously reported Coronavirus infections. In this review, we have investigated the pathogenicity of SARS-CoV-2 and disease susceptibility dependence on the TMPRSS2 gene as expressed in various population groups. We further discuss how the differential expression of this gene in various ethnic groups can affect the SARS-CoV-2 infection and Coronavirus disease (COVID)-19 outcomes. Moreover, promising new TMPRSS2 protease blockers and inhibitors are discussed for COVID-19 treatment.

引用

页码：4205 / 4218

页数：14

共 50 条

[31] Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells [J].

Imperio, Guinever E. ;

Lye, Phetcharawan ;

Mughis, Hafsah ;

Hamada, Hirotaka ;

Bloise, Enrrico ;

Lye, Stephen J. ;

Matthews, Stephen G. .

MICROVASCULAR RESEARCH, 2021, 138

[32] Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [J].

Afewerky, Henok Kessete .

EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 245 (15) :1299-1307

[33] Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 [J].

Ou, Tianling ;

Mou, Huihui ;

Zhang, Lizhou ;

Ojha, Amrita ;

Choe, Hyeryun ;

Farzan, Michael .

PLOS PATHOGENS, 2021, 17 (01)

[34] Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation [J].

Fraser, Bryan J. ;

Beldar, Serap ;

Seitova, Almagul ;

Hutchinson, Ashley ;

Mannar, Dhiraj ;

Li, Yanjun ;

Kwon, Daniel ;

Tan, Ruiyan ;

Wilson, Ryan P. ;

Leopold, Karoline ;

Subramaniam, Sriram ;

Halabelian, Levon ;

Arrowsmith, Cheryl H. ;

Benard, Francois .

NATURE CHEMICAL BIOLOGY, 2022, 18 (09) :963-+

[35] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity [J].

Meng, Bo ;

Abdullahi, Adam ;

Ferreira, Isabella A. T. M. ;

Goonawardane, Niluka ;

Saito, Akatsuki ;

Kimura, Izumi ;

Yamasoba, Daichi ;

Gerber, Pehuen Pereyra ;

Fatihi, Saman ;

Rathore, Surabhi ;

Zepeda, Samantha K. ;

Papa, Guido ;

Kemp, Steven A. ;

Ikeda, Terumasa ;

Toyoda, Mako ;

Tan, Toong Seng ;

Kuramochi, Jin ;

Mitsunaga, Shigeki ;

Ueno, Takamasa ;

Shirakawa, Kotaro ;

Takaori-Kondo, Akifumi ;

Brevini, Teresa ;

Mallery, Donna L. ;

Charles, Oscar J. ;

Bowen, John E. ;

Joshi, Anshu ;

Walls, Alexandra C. ;

Jackson, Laurelle ;

Martin, Darren ;

Smith, Kenneth G. C. ;

Bradley, John ;

Briggs, John A. G. ;

Choi, Jinwook ;

Madissoon, Elo ;

Meyer, Kerstin B. ;

Mlcochova, Petra ;

Ceron-Gutierrez, Lourdes ;

Doffinger, Rainer ;

Teichmann, Sarah A. ;

Fisher, Andrew J. ;

Pizzuto, Matteo S. ;

de Marco, Anna ;

Corti, Davide ;

Hosmillo, Myra ;

Lee, Joo Hyeon ;

James, Leo C. ;

Thukral, Lipi ;

Veesler, David ;

Sigal, Alex ;

Sampaziotis, Fotios .

NATURE, 2022, 603 (7902) :706-+

[36] Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD [J].

Burgueno, Juan F. ;

Reich, Adrian ;

Hazime, Hajar ;

Quintero, Maria A. ;

Fernandez, Irina ;

Fritsch, Julia ;

Santander, Ana M. ;

Brito, Nivis ;

Damas, Oriana M. ;

Deshpande, Amar ;

Kerman, David H. ;

Zhang, Lanyu ;

Gao, Zhen ;

Ban, Yuguang ;

Wang, Lily ;

Pignac-Kobinger, Judith ;

Abreu, Maria T. .

INFLAMMATORY BOWEL DISEASES, 2020, 26 (06) :797-808

[37] Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection [J].

Wettstein, Lukas ;

Immenschuh, Patrick ;

Weil, Tatjana ;

Conzelmann, Carina ;

Almeida-Hernandez, Yasser ;

Hoffmann, Markus ;

Kempf, Amy ;

Nehlmeier, Inga ;

Lotke, Rishikesh ;

Petersen, Moritz ;

Stenger, Steffen ;

Kirchhoff, Frank ;

Sauter, Daniel ;

Poehlmann, Stefan ;

Sanchez-Garcia, Elsa ;

Muench, Jan .

JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)

[38] Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target [J].

Durdagi, Serdar .

TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) :185-+

[39] Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2? [J].

Nascimento, Igor Jose dos Santos ;

de Moura, Ricardo Olimpio .

MEDICINAL CHEMISTRY, 2023, 19 (05) :405-412

[40] Targeting mechanism for SARS-CoV-2 in silico: interaction and key groups of TMPRSS2 toward four potential drugs [J].

Zhao, Xiaoyu ;

Luo, Song ;

Huang, Kaifang ;

Xiong, Danyang ;

Zhang, John Z. H. ;

Duan, Lili .

NANOSCALE, 2021, 13 (45) :19218-19237

← 1 2 3 4 5 →